Niveles sanguíneos de vitamina d en pacientes hipertensos con presión arterial elevada, e hipertensos con normotensiòn en un control ambulatorio
DOI:
https://doi.org/10.22529/me.2024.9(4)07Palabras clave:
vitamina D (VIT D), hipertensión arterial (HTA), renina-angiotensina-aldosterona (RAAS), enfermedad cardiovascular (ECV), parathormona (PTH)Resumen
El déficit de VIT D últimamente se ha relacionado con patologías no músculo esqueléticas, como infecciosas, autoinmunes y cardiovasculares; entre ellas la HTA. Hay evidencia que sugiere que los niveles de VIT D están relacionados inversamente con la presión arterial y el riesgo de desarrollar HTA. Otros estudios asocian este déficit con incremento de mortalidad cardiovascular. El desafío nuestro fue evaluar si el déficit de VIT D es mayor en pacientes hipertensos con presión arterial (PA) elevada, que en hipertensos con normotensión en consultorio, mediante un estudio prospectivo, de dos (2) años de duración, con pacientes entre 33 y 85 años recibidos en consultorio externo de clínica médica, donde se realizó la toma tensión arterial y se dosó nivel sanguíneo de VIT D. Se pidió el consentimiento a cada uno de ellos, aclarando que el objetivo era meramente académico y no recibieron remuneración alguna por su participación. Al analizar los niveles de VIT D, se observó que entre los pacientes con HTA con PA elevada, solo el 38,1% poseían valores de VIT D > 20, mientras que en los HTA con normotensión, ese porcentaje era de 70,59% (p=0.0048).Descargas
Referencias
A Global Brief on Hypertension. Available online: http:/ / apps. who.int / iris / bitstream /10665 / 79059 / 1/ /WHO_DCO_WHD_2013.2_eng.pdf (accessed on 30 October 2017).
Essential Hypertension-Wikipedia. Available from: https://en.wikipedia.org/wiki/Essential_hyperten sion. (Cited 21 Nov 2018).
Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC 7 report. JAMA. 2003 May 21; 289:2560-2572. https://doi.org/10.1001/jama.289.19.2560
Padmanabhan TN, Dani S, V.K. Chopra et al. Prevalence of sympathetic over activity in hypertensive patients-A pan India, noninterventional, cross sectional study. Indian Heart J. 2014; 66:686. https://doi.org/10.1016/j.ihj.2014.10.421
Smith PA, Graham LN, Mackintosh AF, et al. Sympathetic neural mechanisms in white-coat hypertension. J Am Coll Cardiol.2002 Jul 3; 40:126-132. https://doi.org/10.1016/S0735-1097(02)01931-9
Katori M, Majima M. A missing link between a high salt intake and blood pressure increase. J Pharmacol Sci. 2006; 100:370-390. https://doi.org/10.1254/jphs.CRJ06003X
Granger JP, Alexander BT, Llinas M. Mechanisms of pressure natriuresis. Curr Hypertens Rep. 2002 Mar 1; 4:152-159. https://doi.org/10.1007/s11906-002-0040-3
Luscher TF, Noll G, Nava E, et al. Endothelial Dysfunction and Hypertension. In: Vascular Endothelium in Human Physiology and Pathophysiology.2014 Apr 21 (pp.125-146). CRC Press. Available from: https://www.taylorfrancis.com.
Napoli C, Ignarro LJ. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch Pharm Res. 2009; 32:1103-1105. https://doi.org/10.1007/s12272-009-1801-1
Duprez DA. Role of the renin-angiotensinaldosterone system in vascular remodelling and inflammation: a clinical review. J Hypertens.2006 Jun 1; 24:983-989. https://doi.org/10.1097/01.hjh.0000226182.60321.69
Basit S. Vitamin D in health and disease: a literature review. Br J Biomed Sci.2013; 70:161- 72. https://doi.org/10.1080/09674845.2013.11669951
Holick MF. Vitamin D deficiency. N Engl J Med.2007; 357:266-81. https://doi.org/10.1056/NEJMra070553
Kim D. Sabour S, Sagar U, Adams S, Whellan D. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and nutrition examination survey 2001 to 2004).
Zitermann A. Schleithoff SS, Koerfer R. Vitamin D insufficiency in congestive heart failure: why and what to do about it? Heart Fail Rev. 2006; 11:25-33. https://doi.org/10.1007/s10741-006-9190-8
Pekkanen MP, Ukkola O. Hedberg P, Pira OP, Lepojarvi S, Lumme J, Tulppo M, Huikuri H. Serum 25-hydroxyvitamin D is associated with major cardiovascular risk factors and cardiac structure and function in patients with coronary artery disease. Nutr Metab Cardiovasc Dis 2015; 25:471-8. https://doi.org/10.1016/j.numecd.2015.02.005
Giovanucci E, Liu Y, Hollis B, Rimm E 25- hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med.2008; 168:1174-80. https://doi.org/10.1001/archinte.168.11.1174
Wong YYE, Flicker L, Yeap BB, McCaul KA, Hankey GI, Norman PE.Ishipovitaminosia D associated with abdominal aortic aneurysm, and is there a dose-relationship? Eur J Vasc Endovasc Surg.2013; 45:657-64. https://doi.org/10.1016/j.ejvs.2013.03.015
Pavlovic D, Josipovic J. Pavlovic N. Vitamin D and hypertension. Period Biol.2011; 113:299- 302.
Liu E. Melgs JB Pittas AG. Economos CD, Mckeown NM, Booth SL, Jacques PF. Predicted 25-hydroxyvitamin D scrore and incident type 2 diabetes in the Framingham offspring study. Am JClin Nutr. 2010; 91:1627-33. https://doi.org/10.3945/ajcn.2009.28441
Baz-hecht M, Goldfine AB.The impact of vitamin D deficiency on diabetes and cardiovascular risk.Curr Opin Endocrinol Diabetes Obes. 2010; 17:113-9. https://doi.org/10.1097/MED.0b013e3283372859
Martini LA, Wood RJ.Vitamin D status and the metabolic síndrome. Nutr Rev. 2006; 64:479- 86. https://doi.org/10.1111/j.1753-4887.2006.tb00180.x
Chiu KC, Chu A, Go VLW, Saad MF.Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction Am J Clin Nutr. 2004; 79:820-5. https://doi.org/10.1093/ajcn/79.5.820
Rowling MJ, Kemmis CM, Taffany DA, et al. Megalin-mediated endocytosis of vitamin D binding protein correlates with 25-hydroxycholecalciferol actions in human mammary cells. J Nutr. 2006; 136:2754-9. https://doi.org/10.1093/jn/136.11.2754
Pike JW, Zella LA, Meyer MB, et al.Molecular actions of 1, 25-dihydroxyvitamin D3 on genes involved in calcium homeostasis. J Bone Miner Res.2007; 22: V16-9. https://doi.org/10.1359/jbmr.07s207
Artaza JN, Norris KC.Vitamin D reduces the expression of collagenand key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells.J Endocrinol.2009, 200:207-21. https://doi.org/10.1677/JOE-08-0241
Fleck A. Latitude and ischemic heart disease. Lancet.1989; 1:613. https://doi.org/10.1016/S0140-6736(89)91634-6
Grimes DS, Hindle E, Dyer T. Sunlight, cholesterol and coronary heart disease. QJM. 1996; 89:579-89. https://doi.org/10.1093/qjmed/89.8.579
Kendick J, Targher G, Smits G, et al. 25- hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Examination Survey (published online ahead of print November 11,2008). https://doi.org/10.1016/j.atherosclerosis.2008.10.033
Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxivitamin D in the United States:data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007; 167:1159-65. https://doi.org/10.1001/archinte.167.11.1159
Scragg R, Sowers M, Bell C. Serum 25- hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens. 2007; 20:713-9. https://doi.org/10.1016/j.amjhyper.2007.01.017
Melamed ML, Muntner P, Michos ED, et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arteoscler Thromb Vasc Biol.2008; 28:1179-85. https://doi.org/10.1161/ATVBAHA.108.165886
Judd SE, Nanes MS, Ziegler TR, et al. Optimal vitamin D status attenuates the ageassociated increase in systolic blood pressure in white Americans: results from the Third National Health and Nutrition Examination Survey. Am J Clin Nutr. 2008; 87:136-41. https://doi.org/10.1093/ajcn/87.1.136
Hintzpeter B, Mensink GB, Thierfelder W, et al.Vitamin D status and health correlates among German adults.Eur J Clin Nutr.2008;62:1079-89. https://doi.org/10.1038/sj.ejcn.1602825
Snijder MB,Lips P, Seidell JC, et al. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women.J Intern Med.2007;261:558-65. https://doi.org/10.1111/j.1365-2796.2007.01778.x
Melamed ML,Michos ED, Post W, et al.25- hydroxyvitamin D levels and the risk of mortality in the general population.Arch Intern Med.2008;168:1629-37. https://doi.org/10.1001/archinte.168.15.1629
Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation.2008;117:503-11. https://doi.org/10.1161/CIRCULATIONAHA.107.706127
Zitterman A, Schleithoff SS, Koerfer R. Vitamin D and vascular calcification. Curr Opin Lipidol.2007; 18:41-6. https://doi.org/10.1097/MOL.0b013e328011c6fc
Fitzpatrick LA, Bilezikian JP, Silverberg SJ. Parathyroid hormone and the cardiovascular system.Curr Osteopporos Rep.2008; 6:77-83. https://doi.org/10.1007/s11914-008-0014-8
Li, Y.C;Kong, J; Wei, M.; Chen, Z.F.; Liu, S.Q.; Cao,L.P.1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the reninangiotensin system.J.Clin.Investig.2002,110,229-238. https://doi.org/10.1172/JCI15219
Carey, R.M.; Siragy, H.M. The intrarrenal renin-angiotensin system and diabetic nephropathy.Trends Endocrinol.Metab. 2003,14,274-281. https://doi.org/10.1016/S1043-2760(03)00111-5
London GM, Guerin AP, Verbeke FH, et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency.Am Soc Nephrol.2007; 18:613-20. https://doi.org/10.1681/ASN.2006060573
Gradinaru D, Borsa C, Ionescu C, Margina D, Prada GI, Jansen E. Vitamin D status and oxidative stress markers in the elderly with impared fasting glucose and type 2 diabetes mellitus. Aging Clin Exp Res. 2012; 24:595-602. https://doi.org/10.1007/BF03654842
Min B. Effects of vitamin d on blood pressure and endothelial function. Korean J Physiol Pharmacol. 2013; 17:385-92. https://doi.org/10.4196/kjpp.2013.17.5.385
Wakasugi M, Noguchi T, Inoue M, Kazama Y, Tawata M, Kanemaru Y, et al. Vitamin D3 stimulates the production of prostacyclin by vascular smooth muscle cells. Prostaglandins, 1991; 42:127-36. https://doi.org/10.1016/0090-6980(91)90072-N
Lee JH, O Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor. Jam Coll Cardiol. 2008; 52:949-56. https://doi.org/10.1016/j.jacc.2008.08.050
Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ. Prevalence of hypovitaminosis D in cardiovascular dideases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol.2008; 102:1540-4. https://doi.org/10.1016/j.amjcard.2008.06.067
Martins D., Wolf M., Pan D., Zadshir A., Tareen N., Thadhani R., Felsenfeld A., Levine B., Mehrotra R., Norris K. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: Data from the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 2007; 167:1159-1165. [PubMed] [CrossRef] https://doi.org/10.1001/archinte.167.11.1159
Scragg R., Sowers M., Bell C. Serum 25- hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am. J. Hypertens. 2007; 20:713-719. [PubMed] [CrossRef] https://doi.org/10.1016/j.amjhyper.2007.01.017
Jorde R, Figenschau Y, Emaus N. Serum 25- hydroxyvitamin Dlevels are strongly related to systolic blood pressure but do notpredict future hypertension. Hypertension. 2010; 55:792---8.34 https://doi.org/10.1161/HYPERTENSIONAHA.109.143990
Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA,Tworoger SS, Willett WC, et al. Plasma 25-hydroxyvitaminD levels and risk of incident hypertension. Hypertension.2007;49:1063---9.36 https://doi.org/10.1161/HYPERTENSIONAHA.107.087288
Arora P., Song Y., Dusek J., Plotnikoff G., Sabatine M.S., Cheng S., Valcour A., Swales H., Taylor B., Carney E., et al. Vitamin D therapy in individuals with prehypertension or hypertension: The DAYLIGHT trial. Circulation. 2015; 131:254-262. [PubMed] [CrossRef] https://doi.org/10.1161/CIRCULATIONAHA.114.011732
Pilz S., Gaksch M., Kienreich K., Grubler M., Verheyen N., Fahrleitner-Pammer A., Treiber G., Drechsler C., Obermayer-Pietsch B., Schwetz V., et al. Effects of vitamin D on blood pressure and cardiovascular risk factors: A randomized controlled trial. Hypertension. 2015; 65:1195-1201. [PubMed] [CrossRef] https://doi.org/10.1161/HYPERTENSIONAHA.115.05319
Chen W.R., Liu Z.Y., Shi Y., Yin D.W., Wang H., Sha Y., Chen Y.D. Vitamin D and nifedipine in the treatment of Chinese patients with grades I-II essential hypertension: A randomized placebo-controlled trial. Atherosclerosis. 2014; 235:102-109. [PubMed] [CrossRef] https://doi.org/10.1016/j.atherosclerosis.2014.04.011
Alejandro M. Delucchi, Claudio R. Majul, Augusto Vicario, Gustavo H. Cerezo, Guillermo Fábregues. Registro Nacional de Hipertensión Arterial. Características epidemiológicas de la hipertensión arterial en Argentina. Estudio RENATA 2. Revista de la Federación Argentina de Cardiología Vol.46 - Número 2, Abril/junio 2017. http://www.fac.org.ar/2/revista/17v46n2/registr os/01/renata.php.
